AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company") today issued the following statement in connection with the upcoming 2024 Annual Meeting of Stockholders (the "Annual Meeting"), ...
In a special meeting of the board of directors of the Company on December 10, 2024, the Board unanimously voted to honor Dr. Kirby with the posthumous title of Director Emeritus, a recognition of his ...
Deloitte’s report into Cbus governance has given a rare peek under the hood into the nitty-gritty of a super fund’s director selection process, and uncovered the disturbing finding that the board ...